Targeting GRK2 by gene therapy for heart failure: benefits above β-blockade

Gene Therapy
Julia ReinkoberPhilip Raake

Abstract

Heart failure (HF) is a common pathological end point for several cardiac diseases. Despite reasonable achievements in pharmacological, electrophysiological and surgical treatments, prognosis for chronic HF remains poor. Modern therapies are generally symptom oriented and do not currently address specific intracellular molecular signaling abnormalities. Therefore, new and innovative therapeutic approaches are warranted and, ideally, these could at least complement established therapeutic options if not replace them. Gene therapy has potential to serve in this regard in HF as vectors can be directed toward diseased myocytes and directly target intracellular signaling abnormalities. Within this review, we will dissect the adrenergic system contributing to HF development and progression with special emphasis on G-protein-coupled receptor kinase 2 (GRK2). The levels and activity of GRK2 are increased in HF and we and others have demonstrated that this kinase is a major molecular culprit in HF. We will cover the evidence supporting gene therapy directed against myocardial as well as adrenal GRK2 to improve the function and structure of the failing heart and how these strategies may offer complementary and synergistic effects with th...Continue Reading

References

Sep 27, 1984·The New England Journal of Medicine·J N CohnT Rector
Sep 1, 1996·Circulation Research·M UngererG Richardt
May 1, 1997·The Journal of Clinical Investigation·R GrosR D Feldman
Jun 17, 1998·Proceedings of the National Academy of Sciences of the United States of America·H A RockmanW J Koch
Jan 11, 2001·Trends in Cardiovascular Medicine·R B PennJ L Benovic
May 2, 2001·Proceedings of the National Academy of Sciences of the United States of America·V B HardingH A Rockman
Aug 24, 2001·Basic Research in Cardiology·C A HarrisC A Scorer
Jan 24, 2002·Nature·Howard A RockmanRobert J Lefkowitz
Jul 9, 2002·The Journal of Biological Chemistry·Gurpreet Kaur DhamiStephen S G Ferguson
Jul 17, 2003·Physiological Genomics·Burns C BlaxallWalter J Koch
Feb 24, 2004·Annual Review of Physiology·Matthew L Williams, Walter J Koch
Dec 29, 2004·Cardiovascular Research·Guo-Xing ZhangYouichi Abe
May 26, 2005·Cardiovascular Research·Kirsten LeineweberOtto-Erich Brodde
May 16, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Antonio CurcioHoward A Rockman
Feb 27, 2007·Nature Medicine·Anastasios LymperopoulosWalter J Koch
Nov 6, 2007·Trends in Molecular Medicine·Anastasios LymperopoulosWalter J Koch
Jan 29, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Anastasios LymperopoulosWalter J Koch
Jun 21, 2008·Circulation Research·Leif Erik VingeWalter J Koch
Mar 6, 2010·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Shahab A AkhterValluvan Jeevanandam
May 7, 2010·Clinical and Translational Science·Raphael E BonitaWalter J Koch
Jun 26, 2010·Circulation Research·Liam M CaseyBurns C Blaxall
Aug 31, 2010·Journal of Molecular and Cellular Cardiology·Giuseppe RengoWalter J Koch

❮ Previous
Next ❯

Citations

Oct 24, 2012·Nature Reviews. Cardiology·Changwon KhoRoger J Hajjar
May 13, 2014·FEBS Letters·Daisuke AsaiJeong-Hun Kang
Sep 1, 2012·Biochemical Pharmacology·Shaina R EckhouseFrancis G Spinale
Aug 28, 2012·Journal of cardiology·Masatsugu Hori, Hiroshi Okamoto
Feb 29, 2016·European Heart Journal·Jean-Sebastien HulotRoger J Hajjar
Jan 1, 2012·Drug Discovery Today. Therapeutic Strategies·Sarah M Schumacher-BassWalter J Koch
Aug 23, 2016·Circulation Journal : Official Journal of the Japanese Circulation Society·Barry Greenberg
Oct 1, 2013·Journal of Molecular and Cellular Cardiology·Rosy Joshi-MukherjeeLeslie Tung
Nov 24, 2017·Expert Opinion on Therapeutic Targets·Alessandro CannavoGiuseppe Rengo
Aug 28, 2013·Circulation·Min XieJoseph A Hill
May 29, 2014·Molecular Pharmacology·Robert K Amanfu, Jeffrey J Saucerman
Dec 13, 2018·Frontiers in Pharmacology·Supachoke MangmoolHitoshi Kurose
May 26, 2018·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Jun-Ichi Oyama, Koichi Node

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.